On this basis, we established a breast cancer cell line resistant to both epirubicin (EPB) and docetaxel (TXT) through gradual induction, and evaluated the difference in UbcH10 expression between the resistant cell line and its parent cell line. The gene discussed is UBE2C; the disease is breast carcinoma.